In 2000, HES CELL CLINIC started to offer services in preventive medicine, anti-aging, and treatment of chronic diseases. We currently provide two medical services:   A)  Ukraine-based Embryonic Stem Cell Transplantation therapy B)   HES CELL Mesenchymal Stem Cells and Multiplex Growth Factors Therapy, which can increase the success rate of stem cell transplantation.

A)  Ukraine-based Embryonic Stem Cell Transplantation therapy

• Professor Dr. Alexander Smikodub MD. PhD., leader of the Stem Cell Center at the National Medical University of Ukraine, was the first medical expert to apply human embryonic stem cell suspension in treatment programs. In 2004, the HES CELL medical team was commissioned to set up a center in Asia to promote stem cell therapy. The main goal of this center was to promote the knowledge and proper use of stem cell therapy in the Asian region, as well as offering people the opportunities to benefit from this type of treatment. In addition, this opened the door for collaboration between the Asian and Ukrainian medical teams in the research of preventive medicine and the fundamental treatment of chronic diseases.
• As part of the collaboration, HES CELL CLINIC’s doctors are in charge of examining medical cases of Asian patients who want to receive stem cell therapy, and producing a focus report to be delivered to the Stem Cell Center in Ukraine. Based on the report, doctors at the Stem Cell Center will prepare a treatment program customized to the medical condition of a patient; then, the patient will be arranged to receive treatment in Ukraine in a safe and legal environment, under the care of professional medical experts.
• When patients return to their country, HES CELL CLINIC will continue to offer consultations, follow-up examinations and counseling for patients, so patient will receive the proper care and professional treatment that they deserve.

B) HES CELL Mesenchymal Stem Cells and Multiplex Growth Factors Therapy

• Since 2000, HES CELL CLINIC has been deeply involved in the clinical research of protein engineering and polypeptide growth factors. As a result of our long-term partnership with Ukraine’s Stem Cell Center, one of the world’s first medical institutions to use embryonic stem cell therapy program, we have a more comprehensive and in-depth understanding and practice in the prevention and treatment of chronic degenerative diseases.
• HES CELL’s polypeptide nutrient solution was confirmed by cell laboratory with strict standards to contain high quality multiplex growth factor proteins and newly developed mesenchymal stem cells; hence, this supports the validity of our new prescription in increasing the success rate of stem cell transplant. HES CELL medical team has also proven through many clinical cases that the stem cell growth factor and mesenchymal stem cells do increase the success rate of embryonic stem cell transplant, as well as achieve good result in anti-aging and the treatment of chronic diseases.
• The Embryonic stem cell transplant therapy and HES CELL mesenchymal stem cell and multiplex growth factors therapy are no doubt two of the most revolutionary and sophisticated fundamental new medical treatments among emerging medical trends in the 21^st century.

These two therapies were proved to be effective in:

· Increasing a body’s stem cell count

· Enhancing stem cell’s ability to repair lesions

· Treating a variety of chronic diseases

· Enhancing overall physiological functions

· Enhance a body’s ability to repair its organs

· Rejuvenating the organs

· Preventing aging and diseases

​